AstraZeneca faces challenges amid investigation and lawsuit
AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has experienced a significant decline in stock value, plummeting 15 percent over the past six months. This downturn follows alarming reports of a …
AstraZeneca faces challenges amid investigation and lawsuit Read More
